快速访问
文章信息
参考文献
[1]田兴, 孙子含, 陈阳, 等.三苄糖苷有关物质的研究 [J].中国药物化学杂志, 2023, 33(11): 845-848.
[2]JAQUES R. The pharmacological activity of tribenside [J]. Pharmacology, 1977, 15(5): 445-460.
[3]宋丽. 三苄糖苷的质量标准以及注射用头孢曲松钠/舒巴坦钠在犬体内的药代动力学研究 [D]. 四川大学, 2004.
[4]宋丽, 张丹. 三苄糖苷两种异构体HPLC测定方法研究 [J]. 中国药学杂志, 2005(14): 1102-1104.
[5]宋丽, 张丹. HPLC检测三苄糖苷中的有关物质 [J].华西药学杂志, 2004, 19(2): 131-133.
[6]ABDULKHALEQ LA, ASSI MA, ABDULLAH R, et al. The crucial roles of inflammatory mediators in inflammation: A review [J]. Veterinary World, 2018, 11(5): 627-635.
[7]RÜEGG M, JAQUES R. Tribenoside as an Inhibitor of chemically Induced histamine release [J]. Experientia, 1974, 30 (4): 399-401.
[8]LORENC Z, GÖKÇE Ö. Tribenoside and lidocaine in the local treatment of hemorrhoids: an overview of clinical evidence [J]. Eur Rev Med Pharmacol Sci, 2016, 20(12): 2742-2751.
[9]RÜEGG M, RIESTERER L, JAQUES R. Increase of plasma fibrinolysis by Ethyl-tri-O-benzyl-D-glucofuranoside [J]. Pharmacology, 2008, 7(1): 51-61.
[10]HELFER H, JAQUES R. A method for evaluating tone, frequency and 'Venous Output' of the Isolated murine portal vein [J]. Angiologica, 1971, 8(3-5): 172-173.
[11]WILHELMI G. Regeneration-promoting properties of tribenoside in amblystoma mexicanum [J]. Pharmacology, 1976, 14(5): 397–404.
[12]MAlINVERNO M, CALLEGARI E, PIRONA L, et al. Procto-Glyvenol© accelerates the natural healing process of wounds: a pre-clinical study [J]. Eur Rev Med Pharmacol Sci, 2023, 27(17): 8269-8279.
[13]KIKKAWA Y, TAKAKI S, MATSUDA Y, et al. The influence of Tribenoside on expression and deposition of epidermal laminins in HaCaT cells [J]. Biol Pharm Bull, 2010, 33(2): 307-310.
[14]FISCHER D, VANDER LEEK TK, ELLIS AK, et al. Anaphylaxis [J]. Allergy Asthma Clin Immunol, 2018, 14 (Suppl 2): 54.
[15]MAJER H. Stabilization of rat erythrocytes against the haemolytic effect of glass particles by tribenoside [J]. Agents Actions, 1975, 5(2): 161–163.
[16]鲁南制药集团股份有限公司. 一种三苄糖苷的制备方法: 201910478438.3 [P]. 2023-04-07.
[17]US Patent and Trademark Office. Glucofuranosides and process for their preparation: US3157634 [P]. 1964-11-17.
[18]Magyar Tudomanyos Akademia. Glucofuranosides: GB1310382A [P]. 1970-04-07.
[19]山东新时代药业有限公司. 一种三苄糖苷中间体的制备艺: 202210913089.5 [P]. 2024-02-09.
[20]利安隆(天津)实业有限公司. 一种三苄糖苷的合成方法: 201610912665.9 [P]. 2017-04-26.
[21]山东康曼生物科技有限公司. 一种三苄糖苷的制备方法: 201711220450.1 [P]. 2018-02-16.
[22]LOHSIRIWAT V. Treatment of hemorrhoids: A coloproctologist's view. World J Gastroenterol. 2015, 21(31): 9245-9252.
[23]JAQUES R. The activity pattern, in isolated veins, of a benzyl glucofuranoside derivative possessing combined anti-inflammatory and venotropic effects [J]. Pharmacology, 1970, 4(4): 193-202.
[24]RIESTERER L, JAQUES R. Anti-inflammatory action of a benzyl glucofuranoside applied topically [J]. Experientia, 1968, 24(6): 581–582.
[25]HELFER H, JAQUES R. The duration of action of antinociceptive agents as determined in mice using the arachidonic acid writhing test [J]. Pharmacology, 1970, 4(3): 163–168.
[26]赵雪愔. 周身泛发离心性环状红斑1例 [J]. 中国医疗美容, 2013, 3(3): 76-77.
[27]孙达, 李志波, 余永明, 等. 离心性环状红斑17例误诊分析 [J]. 临床误诊误治, 2009, 22(12): 78.
[28]合肥博思科创医药科技有限公司.三苄糖苷在治疗微循环障碍引起的皮肤疾病中的应用: 202011140557.7 [P].2022-08-05.
[29]WOŹNIACKA A, TOKARSKA K, ŻMUDA B. Assessment of vascular circulation in alopecia areata using the FMSF technique [J]. J Clin Med, 2025, 14(10): 3469.
[30]JAQUES, R, KEBERLE, H, RIESTERER, L, et al. On the percutaneous absorption of tribenoside applied topically to the mouse ear [J]. Experientia, 1969, 25 (10): 1023-1024.
[31]MORENO-ARRONES O.M, RODRIGUES-BARATA R, MORALES C. et al. Artículo Traducido Efectos Adversos Graves Por Errores de Formulación de Minoxidil Oral a Bajas Dosis Para el Tratamiento de la Alopecia [J]. Actas Dermo-Sifiliográficas, 2022, 113(7): 725-727.
[32]KALBHEN DA, FELTEN K. Effects of tribenoside (Glyvenol) on experimental osteoarthrosis [J]. Pharmacology, 1979, 19(2): 68-74.
[33]WILHELMI G, FAUST R. Suitability of the C57black mouse as an experimental animal for the study of skeletal changes due to ageing, with special reference to osteo-arthrosis and its response to tribenoside [J]. Pharmacology, 1976, 14(4): 289-296.
[34]BUTLER M, COLOMBO C, HINKMAN L, et al. A new model of osteoarthritis in rabbits. III. Evaluation of anti-osteoarthritic effects of selected drugs administered intraarticularly [J]. Arthritis Rheum, 1983, 26(11): 1380-1386.
[35]CHAYEN J, BITENSKY L, CHAMBERS MG. Modulation of murine osteoarthritis [J]. Cell Biochemistry and Function, 1996, 14(1): 57-61.
[36]EBERHARDT RT, RAFFETTO JD. Chronic venous insufficiency [J]. Circulation, 2014, 130(4): 333-346.
[37]HELFER H, JAQUES R. The venotropic Action of Some anti-Inflammatory compounds. Observations in the isolated murine portal vein [J]. Pharmacology, 1971, 5(1): 23-35.
[38]ZGAŽAROVÁS, JEDLIČKOVÁH, CHOVANCOVÁZ, et al. Pathophysiological characterization of drug hypersensitivity to tribenoside [J]. Cent.Eur.J.Med, 2014, 9(1): 159-168.
[39]KATSUMI I, SHINICHIRO H, TAKATSUKA Y. Assessment of local and systemic availability of tribenoside after rectal administration in rats [J]. International Journal of Pharmaceutics, 1980, 6(1): 43-54.
[40]MCNEIL SE. Nanotechnology for the biologist [J]. J Leukoc Biol, 2005, 78(3): 585-594.
[41]乔明慧, 代柏妍, 郭亦婷, 等. 微针在生物医学中的应用研究进展 [J]. 化学通报, 2025, 88(1): 30-38.
版权与开放获取声明
作为一本开放获取的学术期刊，所有文章均遵循 Creative Commons Attribution 4.0 International License (CC BY 4.0) 协议发布，允许用户在署名原作者的前提下自由共享与再利用内容。所有文章均可免费供读者和机构阅读、下载、引用与传播，EWA Publishing 不会通过期刊的出版发行向读者或机构收取任何费用。